FDA Panel Rejects Arena’s Weight Loss Drug Lorcaserin

FDA Panel Rejects Arena’s Weight Loss Drug Lorcaserin
ADELPHI, Md. – An FDA panel Thursday said the potential risks of tumors, psychiatric effects and heart problems outweighed any benefits of weight loss with Arena Pharmaceuticals Inc.’s Lorquess (lorcaserin).
Read more on BioWorld

Out and about
Times writer Thursday, September 16, 2010 H alfway to st. Patrick’s day celebration They’re already getting revved up for the big “Green Day” celebration. Peggy O’Neill’s lets their Irish pride show with beer, food, contests, giveaways and musical cheer by Peter Robinson, area bagpipers and the Bacardi Boys. 3 p.m. today. Free, with food and drink at an additional cost. Peggy O’Neill’s Irish Pub …
Read more on St. Petersburg Times

FDA Panel Says ‘No’ To Experimental Diet Pill
Federal health experts rejected a highly anticipated weight loss pill Thursday that was thought to offer a safer way to shed pounds than older medications linked to dangerous side effects. The Food and Drug Administration’s panel of experts voted 9-5 against Arena Pharmaceuticals’ drug lorcaserin, saying a series of unresolved safety questions outweighed the drug’s modest benefits.
Read more on CBS4 Miami

WYANDOTTE: Cancer patient pleads for return of her camera’s photo cards
WYANDOTTE — Aug. 24 was turning out to be a great day for Debbie Kibzey.
Read more on The News-Herald

Add a Comment

Your email address will not be published. Required fields are marked *